Importance and review of drug metabolite synthesis

Abstract

Phase I and Phase II metabolic reactions are involved in the pharmacokinetic properties of drugs after administration. These reactions mainly aim to make drugs more polar and eliminate them safely. However, some of these metabolites have the potential to exhibit a toxicological effect. Industry and/or academia have to consider these metabolites in terms of their pharmacodynamic and pharmacokinetic properties. These metabolites are not only residual intermediates from the synthetic process of the main drug but also unique structures produced by metabolic enzymes in the human organism. Thus, metabolite synthesis by synthetic or semi-synthetic methods is a key feature in the pharmaceutical industry. In this review, synthetic methods of the metabolites from all known metabolic pathways are reviewed from the literature. It was observed that both synthetic and semi-synthetic methods require more attention as they are as important and complex as drug synthesis. Moreover, it showed that there was much more research available for Phase I than Phase II in the literature.

Keywords

• Drug metabolite
• metabolism
• synthesis
• oxidation
• Phase I
• Phase II

References

1. Adamczyk, M., & Fino, J. R. (1996). Synthesis of procainamide me-tabolites, N-acetyl desethylprocainamide, and desethylprocain-amide. Organic Preparations and Procedures International, 28(4), 470-474. doi:Doi 10.1080/00304949609356555 google scholar
2. Althuis, T. H., & Hess, H. J. (1977). Synthesis and identification of the major metabolites of prazosin formed in dog and rat. Journal of Medicinal Chemistry, 20(1), 146-149. doi:10.1021/jm00211a031 google scholar
3. Arewang, C. J., Lahmann, M., Oscarson, S., & Tiden, A. K. (2007). Synthesis of urine drug metabolites: glucuronic acid glycosides of phenol intermediates. Carbohydrate Research, 342(7), 970-974. doi:10.1016/j.carres.2007.01.014 google scholar
4. Argikar, U. A. (2012). Unusual glucuronides. Drug Metabolism & Disposition, 40(7), 1239-1251. doi:10.1124/dmd.112.045096 google scholar
5. Asha, S., & Vidyavathi, M. (2009). Cunninghamella--a microbial model for drug metabolism studies--a review. Biotechnology Ad-vances, 27(1), 16-29. doi:10.1016/j.biotechadv.2008.07.005 google scholar
6. Bailey, M. J., & Dickinson, R. G. (2003). Acyl glucuronide reactiv-ity in perspective: biological consequences. Chemico-Biological Interactions, 145(2), 117-137. doi:10.1016/s0009-2797(03)00020-6 google scholar
7. Baillie, T. A., Cayen, M. N., Fouda, H., Gerson, R. J., Green, J. D., Grossman, S. J., . . . Shipley, L. A. (2002). Drug metabolites in safety testing. Toxicology and Applied Pharmacology, 182(3), 188-196. doi:10.1006/taap.2002.9440 google scholar
8. Baldwin, B. C., Robinson, D., & Williams, R. T. (1960). Studies in detoxi-cation. 82. The fate of benzoic acid in some domestic and other birds. The Biochemical Journal, 76(3), 595-600. doi:10.1042/bj0760595 google scholar

9. Boerner, U. (1975). The metabolism of morphine and heroin in man. Drug Metabolism Reviews, 4(1), 39-73. doi:10.3109/03602537508993748 google scholar
10. Bradshaw, P. R., Athersuch, T. J., Stachulski, A. V., & Wilson, I. D. (2020). Acyl glucuronide reactivity in perspective. Drug Discovery Today, 25(9), 1639-1650. doi:10.1016/j.drudis.2020.07.009 google scholar
11. Brown, D. D., Axelrod, J., & Tomchick, R. (1959). Enzymatic N-Methylation of Histamine. Nature, 183(4662), 680-680. doi:10.1038/183680a0 google scholar
12. Cai, X., Sha, M., Guo, C., & Pan, R. M. (2012). Synthesis of Tertiary Amine N-oxides—A Review. Asian Journal of Chemistry, 24(9), 3781-3784. google scholar
13. Caswell, J. M., O’Neill, M., Taylor, S. J., & Moody, T. S. (2013). Engi-neering and application of P450 monooxygenases in pharma-ceutical and metabolite synthesis. Current Opinion in Chemical Biology, 17(2), 271-275. doi:10.1016/j.cbpa.2013.01.028 google scholar
14. Cece-Esensencan, E. N., Fontaine, F., Plasencia, G., Teppner, M., Brink, A., Pahler, A., & Zamora, I. (2016). Enhancing throughput of glutation ad-duct formation studies and structural identification using software as-sisted-workflow based on high-resolution mass spectrometry (HRMS) data. SM Analytical and Bioanalytical Techniques, 1(1002), 1-12. google scholar
15. Chung, K. T., Fulk, G. E., & Egan, M. (1978). Reduction of azo dyes by intestinal anaerobes. Applied and Environmental Microbiology, 35(3), 558-562. doi:10.1128/AEM.35.3.558-562.1978 google scholar
16. Constanzer, M. L., Chavez-Eng, C. M., Fu, I., Woolf, E. J., & Matusze-wski, B. K. (2005). Determination of dextromethorphan and its metabolite dextrorphan in human urine using high performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry: a study of selectivity of a tandem mass spectrometric assay. Journal of Chromatography B, 816(1-2), 297-308. doi:10.1016/j.jchromb.2004.11.049 google scholar
17. Cornelissen, S., Julsing, M. K., Schmid, A., & Buhler, B. (2012). Com-parison of microbial hosts and expression systems for mamma-lian CYP1A1 catalysis. Journal of Industrial Microbiology & Biotech-nology, 39(2), 275-287. doi:10.1007/s10295-011-1026-4 google scholar
18. Correia, M. S. P., Rao, M., Ballet, C., & Globisch, D. (2019). Coupled Enzymatic Treatment and Mass Spectrometric Analysis for Iden-tification of Glucuronidated Metabolites in Human Samples. google scholar
19. Chembiochem, 20(13), 1678-1683. doi:10.1002/cbic.201900065 Çoruh, I. (2012). Synthesis and evaluation of cytotoxic activities of some 1,4-disubstituted thiosemicarbazides, 2,5-disubstituted-1,3,4-thiadiazoles and 1,2,4-triazole-5-thiones derived from ben-zilic acid hydrazide. Marmara Pharmaceutcal Journal, 1(16), 56-63. doi:10.12991/201216421 google scholar
20. Cusack, K. P., Koolman, H. F., Lange, U. E., Peltier, H. M., Piel, I., & Va-sudevan, A. (2013). Emerging technologies for metabolite gener-ation and structural diversification. Bioorganic & Medicinal Chem-istry Letters, 23(20), 5471-5483. doi:10.1016/j.bmcl.2013.08.003 google scholar
21. Dahlin, D. C., & Nelson, S. D. (1982). Synthesis, decomposition ki-netics, and preliminary toxicological studies of pure N-acetyl-p-benzoquinone imine, a proposed toxic metabolite of acetamino-phen. Journal of Medicinal Chemistry, 25(8), 885-886. doi:10.1021/ jm00350a001 google scholar
22. de Paula, N. C., Araujo Cordeiro, K. C., de Melo Souza, P. L., Noguei-ra, D. F., da Silva e Sousa, D. B., Costa, M. B., . . . de Oliveira, V. (2015). Biosynthesis of human diazepam and clonazepam metabo-lites. Bioorganic & Medicinal Chemistry Letters, 25(5), 1026-1029. doi:10.1016/j.bmcl.2015.01.025 google scholar
23. Di Nardo, G., & Gilardi, G. (2012). Optimization of the bacterial cy-tochrome P450 BM3 system for the production of human drug metabolites. International Journal of Molecular Sciences, 13(12), 15901-15924. doi:10.3390/ijms131215901 google scholar
24. Doddaga, S., & Peddakonda, R. (2013). Chloroquine-N-oxide, a ma-jor oxidative degradation product of chloroquine: identification, synthesis and characterization. Journal of Pharmaceutical and Bio-medical Analysis, 81-82, 118-125. doi:10.1016/j.jpba.2013.04.004 google scholar
25. Dutkiewicz, G., Chidan Kumar, C. S., Yathirajan, H. S., Mayekar, A. N., & Kubicki, M. (2009). 3-Methyl-1,2,4-triazolo[3,4-a]phthalazine monohydrate. Acta crystallographica. Section E, Structure reports online, 65(11), o2694. doi:10.1107/S1600536809040677 google scholar
26. Fang, T., Wang, Y., Ma, Y., Su, W., Bai, Y., & Zhao, P. (2006). A rapid LC/ MS/MS quantitation assay for naringin and its two metabolites in rats plasma. Journal of Pharmaceutical and Biomedical Analysis, 40(2), 454-459. doi:10.1016/j.jpba.2005.07.031 google scholar
27. Feely, J., Kavanagh, P. V., McNamara, S. M., & O’Brien, J. E. (1999). Simple preparation of the major urinary metabolites of flunitraz-epam and nitrazepam. Irish Journal of Medical Science, 168(1), 8-9. doi:10.1007/BF02939571 google scholar
28. Fessner, N. D., Srdic, M., Weber, H., Schmid, C., Schonauer, D., Schwaneberg, U., & Glieder, A. (2020). Preparative-Scale Produc-tion of Testosterone Metabolites by Human Liver Cytochrome P450 Enzyme 3A4. Advanced Synthesis & Catalysis, 362(13), 27252738. doi:10.1002/adsc.202000251 google scholar
29. Flores, J. R., Nevado, J. J. B., Salcedo, A. M. C., & Diaz, M. P. C. (2004). Non-aqueous capillary zone electrophoresis method for the analysis of paroxetine, tamoxifen, and their main metabolites in urine. Analytica Chimica Acta, 512(2), 287-295. doi:10.1016/j. aca.2004.02.048 google scholar
30. Fodi, T., Ignacz, G., Decsi, B., Beni, Z., Turos, G. I., Kupai, J., . . . Balogh, G. T. (2018). Biomimetic Synthesis of Drug Metabolites in Batch and Continuous-Flow Reactors. Chemistry, 24(37), 9385-9392. doi:10.1002/chem.201800892 google scholar
31. Food Drug Administration (FDA). (2008). Guidance for industry: safety testing of drug metabolites Retrieved from http://www. fda.gov/CDER/GUIDANCE/fnl.pdf google scholar
32. Foster, A. B., Griggs, L. J., Howe, I., Jarman, M., Leung, C. S., Manson, D., & Rowlands, M. G. (1984). Metabolism of aminoglutethimide in humans. Identification of four new urinary metabolites. Drug Metabolism & Disposition, 12(4), 511-516. google scholar
33. Foster, B. C., Thomas, B. H., Zamecnik, J., Dawson, B. A., Wilson, D. L., Duhaime, R., . . . Lodge, B. A. (1991). Aromatic Hydroxylation and Sul-fation of Phenazopyridine by Cunninghamella-Echinulata. Canadian Journal of Microbiology, 37(7), 504-508. doi:10.1139/m91-085 google scholar
34. Foti, R. S., & Dalvie, D. K. (2016). Cytochrome P450 and non-cy-tochrome P450 oxidative metabolism: Contributions to the 266 pharmacokinetics, safety, and efficacy of xenobiotics. Drug Me-tabolism and Disposition, 44(8), 1229-1245. doi.org/10.1124/ dmd.116.071753 google scholar
35. Fox, H. H., & Gibas, J. T. (1953). Synthetic Tuberculostats. VIII. Acyl Derivatives of Isonicotinyl Hydrazine. The Journal of Organic Chemistry, 18(10), 1375-1379. doi:10.1021/jo50016a018 google scholar
36. Frere, J. M., & Verly, W. G. (1971). O-methylation of noradrenaline and demethylation in rat blood. Biochimica et Biophysica Acta (BBA) - Enzymology, 235(1), 85-88. doi:10.1016/0005-2744(71)90035-0 google scholar
37. Fura, A., Shu, Y. Z., Zhu, M., Hanson, R. L., Roongta, V., & Hum-phreys, W. G. (2004). Discovering Drugs through Biological Trans-formation: Role of Pharmacologically Active Metabolites in Drug Discovery. Journal of Medicinal Chemistry, 47(18), 4339-4351. doi:10.1021/jm040066v google scholar
38. Gao, C., & Zheng, T. (2019). Drug metabolite synthesis by immobi-lized human FMO3 and whole cell catalysts. Microbial Cell Facto-ries, 18(1), 133. doi:10.1186/s12934-019-1189-7 google scholar
39. Geier, M., Bachler, T., Hanlon, S. P., Eggimann, F. K., Kittelmann, M., Weber, H., . . . Winkler, M. (2015). Human FMO2-based microbial whole-cell catalysts for drug metabolite synthesis. Microbial Cell Factories, 14(1), 82. doi:10.1186/s12934-015-0262-0 google scholar
40. Genovino, J., Sames, D., Hamann, L. G., & Toure, B. B. (2016). Ac-cessing Drug Metabolites via Transition-Metal Catalyzed C-H Oxidation: The Liver as Synthetic Inspiration. Angewandte Che-mie International Edition, 55(46), 14218-14238. doi:10.1002/ anie.201602644 google scholar
41. Gill, R., Law, B., & Gibbs, J. P. (1986). High-performance liquid chro-matography systems for the separation of benzodiazepines and their metabolites. Journal of Chromatography A, 356(1), 37-46. doi:10.1016/s0021-9673(00)91465-1 google scholar
42. Gomez de Santos, P., Cervantes, F. V., Tieves, F., Plou, F. J., Hollmann, F., & Alcalde, M. (2019). Benchmarking of laboratory evolved un-specific peroxygenases for the synthesis of human drug metabo-lites. Tetrahedron, 75(13), 1827-1831. doi:10.1016/j.tet.2019.02.013 google scholar
43. Gu, G., Black, M., Cookson, C., Fiorella, A., Li, Y., Gorman, S. H., & Bakhtiar, R. (2018). Validation of an LC-MS/MS method for simul-taneous quantification of venlafaxine and its five metabolites in rat plasma and its application in a pharmacokinetic study. Journal of Chromatography B, 1087-1088, 29-35. doi:10.1016/j. jchromb.2018.04.033 google scholar
44. Hanlon, S. P., Camattari, A., Abad, S., Glieder, A., Kittelmann, M., Lutz, S., . . . Winkler, M. (2012). Expression of recombinant human flavin monooxygenase and moclobemide-N-oxide synthesis on multi-mg scale. Chemical communications, 48(48), 6001-6003. doi:10.1039/c2cc17878h google scholar
45. Helfer, A. G., Michely, J. A., Weber, A. A., Meyer, M. R., & Maurer, H. H. (2015). Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening - exemplified for cardiovas-cular drugs. Analytica Chimica Acta, 891, 221-233. doi:10.1016/j. aca.2015.08.018 google scholar
46. Hoshino, J., Park, E. J., Kondratyuk, T. P., Marler, L., Pezzuto, J. M., van Breemen, R. B., . . . Cushman, M. (2010). Selective synthesis and bi-ological evaluation of sulfate-conjugated resveratrol metabolites. Journal of Medicinal Chemistry, 53(13), 5033-5043. doi:10.1021/ jm100274c google scholar
47. Huber, C., Bartha, B., Harpaintner, R., & Schroder, P. (2009). Me-tabolism of acetaminophen (paracetamol) in plants--two inde-pendent pathways result in the formation of a glutathione and a glucose conjugate. Environmental Science and Pollution Research International, 16(2), 206-213. doi:10.1007/s11356-008-0095-z google scholar
48. Hutt, A. J., & Caldwell, J. (1990). Amino acid conjugation. In G. J. Mulder (Ed.), Conjugation Reactions In Drug Metabolism: An Inte-grated Approach (pp. 273-305). London: CRC Press. google scholar
49. Ishigai, M., Langridge, J. I., & Bordoli, R. S. (2001). A new approach for dynamics of enzyme-catalyzed glutathione conjugation by electrospray quadrupole/time-of-flight mass spectrometry. Ana-lytical Biochemistry, 298(1), 83-92. doi:10.1006/abio.2001.5339 google scholar
50. Ishihara, K., Hamada, H., Hirata, T., & Nakajima, N. (2003). Biotrans-formation using plant cultured cells. Journal of Molecular Catalysis B-Enzymatic, 23(2-6), 145-170. doi:10.1016/S1381-1177(03)00080-8 google scholar
51. Jaworski, T. J., Sardessai, M. S., Aravagiri, M., Lin, G., Shi, Y. Y., Hawes, E. M., . . . Midha, K. K. (1993). Synthesis of the N-oxides of pheno-thiazine antipsychotic agents. Journal of Pharmaceutical Sciences, 82(3), 330-333. doi:10.1002/jps.2600820323 google scholar
52. Kaspersen, F. M., & Van Boeckel, C. A. (1987). A review of the meth-ods of chemical synthesis of sulphate and glucuronide conjugates. Xenobiotica, 17(12), 1451-1471. doi:10.3109/00498258709044005 google scholar
53. Ketterer, B., & Mulder, G. J. (1990). Glutathione conjugation. In G. J. Mulder (Ed.), Conjugation Reactions In Drug Metabolism: An Inte-grated Approach (pp. 307-364). London: CRC Press. google scholar
54. King, A. M., Mullin, L. G., Wilson, I. D., Coen, M., Rainville, P. D., Plumb, R. S., . . . Trengove, R. (2019). Development of a rapid profil-ing method for the analysis of polar analytes in urine using HILIC-MS and ion mobility enabled HILIC-MS. Metabolomics, 15(2), 17. doi:10.1007/s11306-019-1474-9 google scholar
55. Klencsar, B., Sanchez, C., Balcaen, L., Todoli, J., Lynen, F., & Van-haecke, F. (2018). Comparative evaluation of ICP sample in-troduction systems to be used in the metabolite profiling of chlorine-containing pharmaceuticals via HPLC-ICP-MS. Jour-nal of Pharmaceutical and Biomedical Analysis, 153, 135-144. doi:10.1016/j.jpba.2018.02.031 google scholar
56. Kostiainen, R., Kotiaho, T., Kuuranne, T., & Auriola, S. (2003). Liquid chromatography/atmospheric pressure ionization-mass spec-trometry in drug metabolism studies. Journal of Mass Spectrom-etry, 38(4), 357-372. doi:10.1002/jms.481 google scholar
57. Krebsfaenger, N. (2007). Species Comparison of Metabolism in Microsomes and Hepatocytes. In Preclinical Development Hand-book (pp. 919-935). google scholar
58. Kucukguzel, S. G., Kucukguzel, I., Oral, B., Sezen, S., & Rollas, S. (2005). Detection of nimesulide metabolites in rat plasma and hepatic subcellular fractions by HPLC-UV/DAD and LC-MS/MS studies. European Journal of Drug Metabolism and Pharmacokinet-ics, 30(1-2), 127-134. doi:10.1007/BF03226418 google scholar
59. Kuo, F., Gillespie, T. A., Kulanthaivel, P., Lantz, R. J., Ma, T. W., Nelson, D. L., . . . Zmijewski, M. (2004). Synthesis and biological activity of some known and putative duloxetine metabolites. Bioorganic & Medicinal Chemistry Letters, 14(13), 3481-3486. doi:10.1016/j. bmcl.2004.04.066 google scholar
60. Li, S., Klencsar, B., Balcaen, L., Cuyckens, F., Lynen, F., & Vanhaecke, F. (2018). A pre-column derivatization method allowing quantita-tive metabolite profiling of carboxyl and phenolic hydroxyl group containing pharmaceuticals in human plasma via liquid chroma-tography-inductively coupled plasma-tandem mass spectrom-etry (LC-ICP-MS/MS). Journal of Analytical Atomic Spectrometry, 33(2), 274-282. doi:10.1039/c7ja00385d google scholar
61. Lombardino, J. G. (1981). Synthesis and antiinflammatory activity of metabolites of piroxicam. Journal of Medicinal Chemistry, 24(1), 39-42. doi:10.1021/jm00133a009 google scholar
62. Low, L. K., & Castagnoli, J. R. N. (1991). Metabolic changes of drug and related organic compounds. In C. O. Wilson, O. Gisvold, J. H. Block, & J. M. Beale (Eds.), Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry. Philadelphia: Lippincott Williams & Wilkins. google scholar
63. Lu, J., Shang, X., Zhong, W., Xu, Y., Shi, R., & Wang, X. (2020). New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases. Acta Pharmaceutica Si-nica B, 10(1), 91-104. doi:10.1016/j.apsb.2019.11.016 google scholar
64. Luo, H., Hawes, E. M., McKay, G., & Midha, K. K. (1992). Synthesis and characterization of quaternary ammonium-linked gluc-uronide metabolites of drugs with an aliphatic tertiary amine group. Journal of Pharmaceutical Sciences, 81(11), 1079-1083. doi:10.1002/jps.2600811107 google scholar
65. Mackichan, J. J. (1980). Simultaneous Liquid-Chromatographic Analysis for Carbamazepine and Carbamazepine 10,11-Epoxide in Plasma and Saliva by Use of Double Internal Standardization. Journal of Chromatography B, 181(3-4), 373-383. doi:Doi 10.1016/ S0378-4347(00)81140-8 google scholar
66. Michely, J. A., & Maurer, H. H. (2018). A multi-analyte approach to help in assessing the severity of acute poisonings - Development and validation of a fast LC-MS/MS quantification approach for 45 drugs and their relevant metabolites with one-point calibration. Drug Testing and Analysis, 10(1), 164-176. doi:10.1002/dta.2257 google scholar
67. Moody, J. D., Freeman, J. P., Fu, P. P., & Cerniglia, C. E. (2002). Bio-transformation of mirtazapine by Cunninghamella elegans. Drug Metabolism & Disposition, 30(11), 1274-1279. doi:10.1124/ dmd.30.11.1274 google scholar
68. Mulder, G. J. C., Micheal W. H. , & Burchell, B. (1990). Glucuronida-tion, Conjugation Reactions. In G. J. Mulder (Ed.), Conjugation Re-actions In Drug Metabolism: An Integrated Approach (pp. 51-105). London: Taylor Francis. google scholar
69. Nelson, S. D., Garland, W. A., Breck, G. D., & Trager, W. F. (1977). Quantification of lidocaine and several metabolites utilizing chemical-ionization mass spectrometry and stable isotope labeling. Journal of Pharmaceutical Sciences, 66(8), 1180-1190. doi:10.1002/jps.2600660834 google scholar
70. Nobilis, M., Vybiralova, Z., Sladkova, K., Lisa, M., Holcapek, M., & Kvetina, J. (2006). High-performance liquid-chromatographic determination of 5-aminosalicylic acid and its metabolites in blood plasma. Journal of Chromatography A, 1119(1-2), 299-308. doi:10.1016/j.chroma.2006.01.058 google scholar
71. Obach, R. S. (2013). Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy. Pharmacologi-cal Reviews, 65(2), 578-640. doi:10.1124/pr.111.005439 google scholar
72. Otey, C. R., Bandara, G., Lalonde, J., Takahashi, K., & Arnold, F. H. (2006). Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450. Biotechnology & Bioengineering, 93(3), 494-499. doi:10.1002/bit.20744 google scholar
73. Patrick, K. S., Kilts, C. D., & Breese, G. R. (1981). Synthesis and phar-macology of hydroxylated metabolites of methylphenidate. Journal of Medicinal Chemistry, 24(10), 1237-1240. doi:10.1021/ jm00142a021 google scholar
74. Petsalo, A., Turpeinen, M., Pelkonen, O., & Tolonen, A. (2008). Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2 microm particle size column. Jour-nal of Chromatography A, 1215(1-2), 107-115. doi:10.1016/j.chro-ma.2008.10.122 google scholar
75. Pohland, A., Boaz, H. E., & Sullivan, H. R. (1971). Synthesis and iden-tification of metabolites resulting from the biotransformation of DL-methadone in man and in the rat. Journal of Medicinal Chem-istry, 14(3), 194-197. doi:10.1021/jm00285a004 google scholar
76. Protti, M., Marasca, C., Cirrincione, M., Cavalli, A., Mandrioli, R., & Mercolini, L. (2020). Assessment of capillary volumetric blood mi-crosampling for the analysis of central nervous system drugs and metabolites. Analyst, 145(17), 5744-5753. doi:10.1039/d0an01039a google scholar
77. Pryde, J., & Williams, R. T. (1933). The biochemistry and physiol-ogy of glucuronic acid: The structure of glucuronic acid of animal origin. The Biochemical Journal, 27(4), 1197-1204. doi:10.1042/ bj0271197 google scholar
78. Rasheed, A., Kumar, C. K. A., Shama, S. N., & Mishra, A. (2011). Syn-thesis and Pharmacological Evaluation of Tyrosine and Glycine Prodrugs of Aceclofenac. Jordan Journal of Pharmaceutical Sci-ences, 4(3), 198-208. google scholar
79. Reddy, G. M., Mukkanti, K., Bhaskar, B. V., & Reddy, P. P. (2008). Syn-thesis of Metabolites and Related Substances of Rabeprazole, an Anti-Ulcerative Drug. Synthetic Communications, 39(2), 278-290. doi:10.1080/00397910802372541 google scholar
80. Reddy, G. M.,Mukkanti,K.,Kumar,T.L., Babu,J.M.,&Reddy,P.P.(2008). Synthesis and Characterization of Metabolites and Potential Im-purities of Lansoprazole, an Antiulcerative Drug. Synthetic Com-munications, 38(20), 3477-3489. doi:10.1080/00397910802162934 google scholar
81. Ren, J. L., Zhang, A. H., Kong, L., & Wang, X. J. (2018). Advances in mass spectrometry-based metabolomics for investigation of metabolites. RSC Advances, 8(40), 22335-22350. doi:10.1039/ c8ra01574k google scholar
82. • Rice, K. C. (1977). A rapid, high-yield conversion of codeine to morphine. Journal of Medicinal Chemistry, 20(1), 164-165. doi:10.1021/jm00211a036 google scholar
83. • Rinnofner, C., Kerschbaumer, B., Weber, H., Glieder, A., & Winkler, M. (2019). Cytochrome P450 mediated hydroxylation of ibupro-fen using Pichia pastoris as biocatalyst. Biocatalysis and Agricul-tural Biotechnology, 17, 525-528. doi:10.1016/j.bcab.2018.12.022 google scholar
84. Rollas, S. (2007). In Vivo Metabolism in Preclinical Drug Develop-ment. In S. C. Gad (Ed.), Preclinical Development Handbook (pp. 829-851): John Wiley & Sons, Inc. google scholar
85. Rollas, S. (2010). Reduction of aromatic and heteroaromatic azo compounds with hydrazine hydrate. Marmara Pharmaceutcal Journal, 1(14), 41-46. doi:10.12991/201014458 google scholar
86. Sang, S., Lambert, J. D., Ho, C. T., & Yang, C. S. (2011). The chem-istry and biotransformation of tea constituents. Pharmacological Research, 64(2), 87-99. doi:10.1016/j.phrs.2011.02.007 google scholar
87. Sawayama, A. M., Chen, M. M., Kulanthaivel, P., Kuo, M. S., Hemmer-le, H., & Arnold, F. H. (2009). A panel of cytochrome P450 BM3 vari-ants to produce drug metabolites and diversify lead compounds. Chemistry, 15(43), 11723-11729. doi:10.1002/chem.200900643 google scholar
88. Schaber, G., Wiatr, G., Wachsmuth, H., Dachtler, M., Albert, K., Gaertner, I., & Breyer-Pfaff, U. (2001). Isolation and identification of clozapine metabolites in patient urine. Drug Metabolism & Dispo-sition, 29(6), 923-931. google scholar
89. Schroer, K., Kittelmann, M., & Lutz, S. (2010). Recombinant human cytochrome P450 monooxygenases for drug metabolite synthe-sis. Biotechnology & Bioengineering, 106(5), 699-706. doi:10.1002/ bit.22775 google scholar
90. Sidelmann, U. G., Christiansen, E., Krogh, L., Cornett, C., Tjornelund, J., & Hansen, S. H. (1997). Purification and 1H NMR spectroscopic characterization of phase II metabolites of tolfenamic acid. Drug Metabolism & Disposition, 25(6), 725-731. google scholar
91. Sinha, S. K., Praveen, B., Shrivastava, P. K., & Shrivastava, S. K. (2012). Synthesis, characterization and biological evaluation of some glutathione inducing amino acid conjugates ofvalproic acid with reduced hepatotoxicity. Asian Pacific Journal of Tropical Disease, 2, 218-222. doi:10.1016/s2222-1808(12)60155-8 google scholar
92. Smith, D. A., & Obach, R. S. (2005). Seeing through the mist: abundance versus percentage. Commentary on metabolites in safety testing. Drug Metabolism & Disposition, 33(10), 1409-1417. doi:10.1124/dmd.105.005041 google scholar
93. Stachulski, A. V., & Meng, X. (2013). Glucuronides from metabo-lites to medicines: a survey of the in vivo generation, chemical synthesis and properties of glucuronides. Natural Product Reports, 30(6), 806-848. doi:10.1039/c3np70003h google scholar
94. Stalder, R., & Roth, G. P. (2013). Preparative microfluidic electrosyn-thesis of drug metabolites. ACS Medicinal Chemistry Letters, 4(11), 1119-1123. doi:10.1021/ml400316p google scholar
95. Steinbrecht, S., Kiebist, J., König, R., Thiessen, M., Schmidtke, K.-U., Kammerer, S., . . . Scheibner, K. (2020). Synthesis of cyclophospha-268 _________________________________mide metabolites by a peroxygenase from Marasmius rotula for toxicological studies on human cancer cells. AMB Express, 10(1), 128. doi:10.1186/s13568-020-01064-w. (Accession No. 32683510) google scholar
96. Strachan, R. G., Meisinger, M. A. P., Ruyle, W. V., Hirschmann, R., & Shen, T. Y. (1964). Synthesis of Indomethacin Metabolites. Journal of Medicinal Chemistry, 7(6), 799-800. doi:10.1021/jm00336a026 google scholar
97. Sun, H., Moore, C., Dansette, P. M., Kumar, S., Halpert, J. R., & Yost, G. S. (2009). Dehydrogenation of the Indoline-Containing Drug 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (In-dapamide) by CYP3A4: Correlation with in Silico Predictions. Drug Metabolism and Disposition, 37(3), 672-684. doi:10.1124/ dmd.108.022707 google scholar
98. Sun, L., Huang, H.-H., Liu, L., & Zhong, D.-F. (2004). Transforma-tion of Verapamil by Cunninghamella blakesleeana. Applied and Environmental Microbiology, 70(5), 2722-2727. doi:10.1128/ AEM.70.5.2722-2727.2004 google scholar
99. Sundell, J., Bienvenu, E., Birgersson, S., Abelo, A., Ashton, M., & Hoffmann, K. J. (2019). Simultaneous quantification of four first line antitubercular drugs and metabolites in human plasma by hydrophilic interaction chromatography and tandem mass spectrometry. Journal of Chromatography B, 1105, 129-135. doi:10.1016/j.jchromb.2018.10.027 google scholar
100. Turgeon, J., Pare, J. R., Lalande, M., Grech-Belanger, O., & Belanger, P. M. (1992). Isolation and structural characterization by spectro-scopic methods of two glucuronide metabolites of mexiletine after N-oxidation and deamination. Drug Metab Dispos, 20(5), 762-769. google scholar
101. Uldam, H. K., Juhl, M., Pedersen, H., & Dalgaard, L. (2011). Biosyn-thesis and identification of an N-oxide/N-glucuronide metabo-lite and first synthesis of an N-O-glucuronide metabolite of Lu AA21004. Drug Metabolism & Disposition, 39(12), 2264-2274. doi:10.1124/dmd.111.040428 google scholar
102. Vail, R. B., Homann, M. J., Hanna, I., & Zaks, A. (2005). Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli. Journal of Industrial Microbiology and Biotechnol-ogy, 32(2), 67-74. doi:10.1007/s10295-004-0202-1 google scholar
103. Valero, E., Lozano, M. I., Varon, R., & Garcia-Carmona, F. (2003). Enzymatic synthesis of 3’-hydroxyacetaminophen catalyzed by tyrosinase. Biotechnology Progress, 19(6), 1632-1638. doi:10.1021/ bp034075t google scholar
104. Wang, Z., Sun, W., Lin, Z. F., Sun, R., Huang, C. K., Ye, W. J., . . . Chen, R. J. (2019). A UHPLC-MS/MS method coupled with liquid-liquid extraction for the quantitation of phenacetin, omeprazole, meto-prolol, midazolam and their metabolites in rat plasma and its ap-plication to the study of four CYP450 activities. Journal of Phar-maceutical and Biomedical Analysis, 163, 204-210. doi:10.1016/j. jpba.2018.10.012 google scholar
105. Weis, R., Winkler, M., Schittmayer, M., Kambourakis, S., Vink, M., Ro-zzell, J. D., & Glieder, A. (2009). A Diversified Library of Bacterial and Fungal Bifunctional Cytochrome P450 Enzymes for Drug Metabo-lite Synthesis. Advanced Synthesis & Catalysis, 351(13), 2140-2146. doi:10.1002/adsc.200900190 google scholar
106. Wheals, B. B., & Jane, I. (1977). Analysis of drugs and their metabo-lites by high-performance liquid chromatography. A review. Ana-lyst, 102(1218), 625-644. doi:10.1039/an9770200625 google scholar
107. Williams, R. T. (1938). Studies in detoxication. II. (a) The conju-gation of isomeric 3-menthanols with glucuronic acid and the asymmetric conjugation of dl-menthol and dl-isomenthol in the rabbit. (b) d-isoMenthylglucuronide, a new conjugated glucuron-ic acid. The Biochemical Journal, 32(10), 1849-1855. doi:10.1042/ bj0321849 google scholar
108. Williams, R. T. (1943). Studies in detoxication: 13. The biosynthesis of aminophenyl- and sulphonamidoaminophenylglucuronides in the rabbit and their action on haemoglobin in vitro. Biochemi-cal Journal, 37(3), 329-333. google scholar
109. Winkler, M., Geier, M., Hanlon, S. P., Nidetzky, B., & Glieder, A. (2018). Human Enzymes for Organic Synthesis. Angewandte Che-mie International Edition, 57(41), 13406-13423. doi:https://doi. org/10.1002/anie.201800678 google scholar
110. Wu, Y, Wang, R, Yang, H., & Sui, F. (2019). UPLC-Q-TOF-MS and UPLC-MS/MS methods for metabolism profiles and pharmacokinetics of major compounds in Xuanmai Ganjie Granules. Biomedical Chroma-tography, 33(3), e4449. doi:https://doi.org/10.1002/bmc.4449 google scholar
111. Xing, J., Zang, M., Zhang, H., & Zhu, M. (2015). The application of high-resolution mass spectrometry-based data-mining tools in tandem to metabolite profiling of a triple drug combination in humans. Analytica Chimica Acta, 897, 34-44. doi:10.1016/j. aca.2015.09.034 google scholar
112. Yoshimura, H., Oguri, K., & Tsukamoto, H. (1968). Metabolism of drugs. LX. The synthesis of codeine and morphine glucuronides. Chemical and Pharmaceutical Bulletin, (Tokyo), 16(11), 2114-2119. doi:10.1248/cpb.16.2114 google scholar
113. Youssif, S. (2001). Recent trends in the chemistry of pyridine N-oxides. J Arkivoc, 1, 242-268. google scholar
114. Zhang, D., Freeman, J. R., Sutherland, J. B., Walker, A. E., Yang, Y., & Cerniglia, C. E. (1996). Biotransformation of chlorpromazine and methdilazine by Cunninghamella elegans. Applied and Environ-mental Microbiology, 62(3), 798-803. doi:10.1128/AEM.62.3.798-803.1996 google scholar
115. Schroer, K., Kittelmann, M., & Lutz, S. (2010). Recombinant human cytochrome R450 monooxygenases for drug metabolite synthe-sis. Biotechnology & Bioengineering, 106(5), 699-706. google scholar